A detailed history of Bam Wealth Management, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Bam Wealth Management, LLC holds 7,799 shares of EXEL stock, worth $296,829. This represents 0.25% of its overall portfolio holdings.

Number of Shares
7,799
Holding current value
$296,829
% of portfolio
0.25%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 31, 2025

BUY
$36.22 - $46.25 $282,479 - $360,703
7,799 New
7,799 $322 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $12.2B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Bam Wealth Management, LLC Portfolio

Follow Bam Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bam Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bam Wealth Management, LLC with notifications on news.